PapersPMID:30771686
Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial).
What moved
1 findingHow to read these marks →“However, the omega-3 index increased more than two-fold in the fish oil group only (7.2 ± 1.2% increase from baseline, P < 0.001; between group differential P < 0.001).”
- Study
- RCT
- Dose studied
- 4.4 g/day, four capsules twice daily, for 3 months
- Population
- Male veterans aged 50 years or older with peripheral artery disease and intermittent claudication (11 randomised to fish oil, 13 to soybean oil placebo), after 3 months
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Male veterans with peripheral artery disease and intermittent claudication (Rutherford I-III), San Francisco VA Medical Center; fish oil (ProOmega, ethyl-ester/triglyceride form not stated) versus soybean oil placebo
- Participants
- 24
- Comparator
- placebo
- Duration
- 91 days
- Endpoints measured
- 21